Dividend Upstreaming versus Local Solvency
Alpha Group has a UK life subsidiary, Alpha UK, and a Bermudan reinsurance affiliate, Alpha Re. Alpha UK's Solvency II ratio is 138%, below the board's 145% operating target but above the regulatory capital requirement of 100%. Its annuity book relies on the matching adjustment, and credit spreads have widened by 80 basis points over the quarter, increasing balance sheet volatility. Alpha Re has a group ratio of 165% on its internal model. Group treasury proposes a £200m dividend from Alpha UK to fund a share buyback, arguing that surplus capital is trapped and dragging down return on equity. The PRA has signalled concern about Alpha UK's sensitivity to spread widening and has asked for the ORSA to demonstrate resilience under a 1-in-200 stress. The board must decide whether to approve the dividend, and if not, what alternative capital action to take. The group CFO notes that the buyback is already announced to the market.
1. Evaluate the fungibility of capital across the group and the constraints on upstreaming the dividend, including regulatory, rating agency and policyholder considerations.
Read the worked answer
Fungibility is constrained by three things: regulatory ring-fencing, the matching adjustment, and rating agency expectations. Alpha UK's 138% ratio is only 38 points above the SCR; a 1-in-200 stress could consume much of that, and the PRA has already flagged spread sensitivity. The matching adjustment permission makes the balance sheet sensitive to credit spreads; an 80bp widening increases volatility and may reduce the ratio. Upstreaming £200m would reduce the ratio by roughly 20-25 points, taking it close to 115%, above 100% but below the board's 145% target and likely below the level the PRA expects for a firm with matching adjustment concentration. Policyholder protections and the ORSA's own risk assessment also matter. A group ratio of 165% does not help if the capital is not freely transferable: Alpha Re's capital may not be available to support Alpha UK without collateral or regulatory approval. Rating agencies assess group and entity capital separately, and an announced buyback that is then constrained would be worse than a delay.
2. Recommend a capital management decision and a contingency plan, setting out the trade-offs between the buyback, retaining capital and alternative uses.
Read the worked answer
I would not approve the full £200m dividend now. Instead, approve a smaller dividend of £80-100m, subject to PRA non-objection and a stress test showing the ratio stays above 120% under a 1-in-200 spread widening. Retain the balance to protect the matching adjustment and fund the ORSA stress. For the buyback, consider a smaller programme or a delay, and communicate to the market with a clear rationale: capital strength and regulatory dialogue. The contingency plan should: (i) identify alternative capital sources such as subordinated debt, reinsurance or a capital raise; (ii) set triggers at 130% and 125% for reducing the dividend and de-risking; (iii) review the matching adjustment portfolio for liquidity and collateral calls. The trade-offs are real: a buyback improves ROE and signals confidence, but at the cost of reduced buffer and potential regulatory friction. Retaining capital reduces ROE but preserves optionality. The announced buyback creates reputational risk if cancelled; a phased approach and transparent communication mitigate it.